Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer

被引：0
|
作者：
Tuerkmen, B.
Schmitt, M.
Schmalfeldt, B.
Trommler, P.
机构：
来源：
Electrophoresis | / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects
    Schmitt, Manfred
    Mengele, Karin
    Gkazepis, Apostolos
    Napieralski, Rudolf
    Magdolen, Viktor
    Reuning, Ute
    Harbeck, Nadia
    BREAST CARE, 2008, 3 : 3 - 10
  • [32] Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients
    Kowal, Krzysztof
    Zukowski, Sebastian
    Moniuszko, Marcin
    Bodzenta-Lukaszyk, Anna
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2008, 46 (02) : 193 - 198
  • [33] Urokinase-like plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in primary breast cancer - Predictive markers for tamoxifen resistance?
    Kahlert, S
    Boettcher, B
    Konecny, G
    Bauerfeind, I
    Nestle-Kraemling, C
    Untch, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S82 - S82
  • [34] ROLE OF PLASMA LEVEL OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 (PAI 1), ITS GENE POLYMORPHISM AND INHIBITOR OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) IN TUMOUR TISSUE IN COLORECTAL CARCINOMA PATIENTS
    Halamkova, J.
    Kiss, I.
    Pavlovsky, Z.
    Cech, Z.
    Tomasek, J.
    Tucek, S.
    Svobodnik, A.
    Hanakova, L.
    Moulis, M.
    Penka, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 149 - 149
  • [35] Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer
    Tecimer, C
    Doering, DL
    Goldsmith, LJ
    Meyer, JS
    Abdulhay, G
    Wittliff, JL
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (05) : 372 - 381
  • [36] Production of Urokinase-Type Plasminogen Activator (u-PA) and Plasminogen Activator Inhibitor-1 (PAI-1) in Human Brain Tumours
    Y. Arai
    T. Kubota
    T. Nakagawa
    M. Kabuto
    K. Sato
    H. Kobayashi
    Acta Neurochirurgica, 1998, 140 : 377 - 386
  • [37] Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours
    Arai, Y
    Kubota, T
    Nakagawa, T
    Kabuto, M
    Sato, K
    Kobayashi, H
    ACTA NEUROCHIRURGICA, 1998, 140 (04) : 377 - 386
  • [38] Clinical relevance of urokinase-type plasminogen activator and its inhibitor type I (PAI-1) in squamous cell carcinoma of the uterine cervix
    Horn, LC
    Pippig, S
    Raptis, G
    Fischer, U
    Köhler, U
    Hentschel, B
    Martin, R
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2002, 42 (04): : 383 - 386
  • [39] RETINAL-PIGMENT EPITHELIAL-CELLS SECRETE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PAI-1
    SIREN, V
    STEPHENS, RW
    SALONEN, EM
    VAHERI, A
    SUMMANEN, P
    IMMONEN, I
    OPHTHALMIC RESEARCH, 1992, 24 (04) : 203 - 212
  • [40] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PAI-1 - PREDICTORS OF POOR RESPONSE TO TAMOXIFEN THERAPY IN RECURRENT BREAST-CANCER
    FOEKENS, JA
    LOOK, MP
    PETERS, HA
    VANPUTTEN, WLJ
    PORTENGEN, H
    KLIJN, JGM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (10) : 751 - 756
12345